Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased

Neuropharmacology

Volumn 62, Issue 3, 2012, Pages 1432-1441

  Barnes, Sam A ^a   Young, Jared W ^b   Neill, Jo C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 Choice Continuous Performance Test; Attention; PCP; Rat; Schizophrenia; Vigilance

Indexed keywords

PHENCYCLIDINE;

5 CHOICE CONTINUOUS PERFORMANCE TEST; ACCURACY; ALERTNESS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; FEMALE; INTERMETHOD COMPARISON; LATENT PERIOD; MENTAL PERFORMANCE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RAT; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TASK PERFORMANCE;

ANIMALS; ATTENTION; CHOICE BEHAVIOR; FEMALE; PHENCYCLIDINE; PSYCHOMOTOR PERFORMANCE; RANDOM ALLOCATION; RATS; TIME FACTORS;

EID: 84856093125     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.04.024     Document Type: Article

References (88)

1. Z. Abdul-Monim, J.C. Neill, and G.P. Reynolds Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbuminimmunoreactive expression in the rat J. Psychopharmacol. 21 2007 198 205 (Pubitemid 46280471)
2. R.M. Allen, and S.J. Young Phencyclidine-induced psychosis Am. J. Psychiatry 135 1978 1081 1084 (Pubitemid 8395441)
3. N. Amitai, S. Semenova, and A. Markou Cognitive disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medication in rats Psychopharmacology (Berl.) 193 2007 521 537 (Pubitemid 47094377)
4. N. Amitai, and A. Markou Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration Psychopharmacology 202 2009 275 286
5. N. Amitai, and A. Markou Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-d-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia Biol. Psychiatry 68 2010 5 16
6. A.L. Auclair, J. Besnard, A. Newman-Tancredi, and R. Depoortere The five choice serial reaction time task: comparison between Sprague-Dawley and Long-Evans rats on acquisition of the task, and sensitivity to phencyclidine Pharmacol. Biochem. Behav. 92 2009 363 369
7. J.P. Baerwald, W.W. Tyron, and J. Sandford Bimodal response sensitivity and bias in a test of sustained attention contrasting patients with schizophrenia and bipolar disorder to normal comparison group Arch. Clin. Neuropsychol. 20 2005 17 32 (Pubitemid 40029806)
8. A. Bari, J.W. Dalley, and T.W. Robbins The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats Nat. Protoc. 3 5 2008 759 767 (Pubitemid 351639020)
9. C. Baunez, and T.W. Robbins Effects of dopamine depletion in the dorsal striatum and further interaction with subthalamic nucleus lesion in an attentional task in rats Neuroscience 92 1999 1343 1356 (Pubitemid 29292570)
10. M. Baviera, R.W. Invernizzi, and M. Carli Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC Psychopharmacology 196 2008 269 280
11. R.W. Buchanan, M. Davis, D. Goff, M.F. Green, R.S.E. Keefe, A.C. Leon, K.H. Nuechterlein, T. Laughren, R. Levin, E. Stover, W. Fenton, and S.R. Marder A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia Schizophr. Bull. 31 1 2005 5 19 (Pubitemid 41214353)
12. M. Carli, T.W. Robbins, J.L. Evenden, and B.J. Everitt Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal Behav. Brain Res. 9 1983 361 380 (Pubitemid 13002330)
13. A.S. Carlin, I. Grant, K.M. Adams, and R. Reed Is phencyclidine (PCP) abuse associated with organic mental impairment? Am. J. Drug Alcohol Abuse 6 3 1978 273 281 (Pubitemid 10163596)
14. A. Carlsson The dopamine theory revisited S.R. Hirsch, D.R. Weinberger, Schizophrenia 1995 Blackwell Science Oxford, UK 379 400
15. Y. Chudasama, F. Passetti, S.E.V. Rhodes, D. Lopian, A. Desai, and T.W. Robbins Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulated cortex, infralimbic cortex and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity Behav. Brain Res. 156 1-2 2003 105 119 (Pubitemid 37476138)
16. S.M. Cochran, M. Kennedy, C.E. McKerchar, L.J. Steward, J.A. Pratt, and B.J. Morris Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs Neuropsychopharmacology 28 2003 265 275
17. B.J. Cole, and T.W. Robbins Forebrain norepinephrine: role in effortful but not automatic processing in the rat Neuropsychopharmacology 7 1992 129 142
18. R.D. Collings Differences between ADHD inattentive and combined types on the CPT J. Psychopathol. Behav. Assess. 25 2003 177 189 (Pubitemid 36687529)
19. B.A. Cornblatt, and J.G. Keilp Impaired attention, genetics, and the pathophysiology of schizophrenia Schizophr. Bull. 20 1 1994 31 46 (Pubitemid 24071091)
20. B.A. Cornblatt, and A.K. Malhotra Impaired attention as an endophenotype for molecular genetic studies of schizophrenia Am. J. Med. Genet. 105 2001 11 15 (Pubitemid 32105185)
21. J. Cosgrove, and T.G. Newell Recovery of neuropsychological functions during reduction in use of phencyclidine J. Clin. Psychol. 47 1 1991 159 169
22. J.T. Coyle Glutamate and schizophrenia: beyond the dopamine hypothesis Cell. Mol. Neurobiol. 26 4-6 2006 365 384
23. J.W. Dalley, J. McGaughy, M.T. O'Connell, R. Cardinal, L. Levita, and T.W. Robbins Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and non-contingent performance of a visual attentional task J. Neurosci. 21 2001 4908 4914 (Pubitemid 32565649)
24. J.W. Dalley, D.E. Theobald, E.A.C. Pereira, P.M. Li, and T.W. Robbins Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity Psychopharmacology 164 2002 329 340 (Pubitemid 35341000)
25. J.W. Dalley, D.E. Theobald, P. Bouger, Y. Chudasama, R.N. Cardinal, and T.W. Robbins Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesion of the medial prefrontal cortex Cereb. Cortex 14 2004 54 64
26. P. Dudchenko, B. Paul, and M. Sarter Dissociation between the effects of benzodiazepine receptor agonists on behavioural vigilances and responsivity Psychopharmacology 109 1992 203 211
27. D.M. Eagle, A. Bari, and T.W. Robbins The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks Psychopharmacology 199 2008 439 456
28. J. Egeland, S.N. Johansen, and T. Ueland Differentiating between ADHD sub-types on CCPT measures of sustained attention and vigilance Scand. J. Psychol. 50 2009 347 354
29. G. Fattorini, M. Melone, L. Bragina, C. Candiracci, A. Cozzi, D.E.P. Giampietro, M. Torres-Ramos, A. Perez-Samartin, C. Matute, and F. Conti GLT-1 expression and Glu uptake in rat cerebral cortex are increased by phencyclidine Glia 56 2008 1320 1327
30. P. Frey, and J.A. Colliver Sensitivity and responsibility measures for discrimination learning Learning and Motivation 4 1973 327 342
31. D.C. Goff, and J.T. Coyle The emerging role of glutamate in the pathophysiology and treatment of schizophrenia Am. J. Psychiatry 158 2001 1367 1377 (Pubitemid 32847232)
32. A.J. Grottick, and G.A. Higgins Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task Behav. Brain Res. 117 2000 197 208
33. A.J. Grottick, and G.A. Higgins Assessing a vigilance decrement in aged rats: effects of pre-feeding, task manipulation, and psychostimulants Psychopharmacology 164 1 2002 33 41 (Pubitemid 35203840)
34. B. Hahn, M. Shoaib, and I.P. Stolerman Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands Psychopharmacology 162 2002 129 137 (Pubitemid 34743952)
35. B. Hahn, C.G. Sharples, S. Wonnacott, M. Shoaib, and I.P. Stolerman Attentional effects of nicotine agonists in rats Neuropharmacology 44 8 2003 1054 1067 (Pubitemid 36570430)
36. T. Hajszan, C. Leranth, and R.H. Roth Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex Biol. Psychiatry 60 2006 639 644 (Pubitemid 44402369)
37. 2A agonist and NMDA antagonist model of psychosis Psychopharmacology 199 2008 77 88
38. J.L. Herreo, M.J. Roberts, L.S. Delicato, M.A. Gieselmann, P. Dayan, and A. Thiele Acetylcholine contributes through muscarinic receptors to attentional modulation in V1 Nature 2008
39. H.M. Ibrahim, and C.A. Tamminga Schizophrenia: treatment targets beyond monoamine systems Annu. Rev. Pharmacol. Toxicol. 51 2010 189 209
40. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am. J. Psychiatry 148 10 1991 1301 1308
41. T.A. Jenkins, M.K. Harte, C.E. McKibben, J.J. Elliott, and G.P. Reynolds Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat Behav. Brain Res. 194 2 2008 230 235
42. J.D. Jentsch, D.E. Redmond, J.D. Elswood, J.R. Taylor, K.D. Youngren, and R.H. Roth Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine Science 277 1997 953 955 (Pubitemid 27366680)
43. J.D. Jentsch, A. Tran, D. Le, K.D. Youngren, and R.H. Roth Sub-chronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat Neuropsychopharmacology 17 1997 92 99
44. J.D. Jentsch, L. Dazzi, J.P. Chhatwal, C.D. Verrico, and R.H. Roth Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats Neurosci. Lett. 258 1998 175 178 (Pubitemid 29023576)
45. J.D. Jentsch, and R.H. Roth The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 3 1999 201 225 (Pubitemid 29067401)
46. D.N.C. Jones, J.C. Barnes, D.L. Kirkby, and G.A. Higgins Age-associated impairments in a test of attention: evidence for involvement of cholinergic systems J. Neurosci. 15 11 1995 7282 7292
47. R.S. Kern, K.H. Nuechterlein, M.F. Green, L.E. Baade, W.S. Fenton, J.M. Gold, R.S. Keefe, R. Mesholam-Gately, J. Mintz, L.J. Seidman, E. Stover, and S.R. Marder The MATRICS consensus cognitive battery, part 2: co-norming and standardization Am. J. Psychiatry 165 2 2008 214 220 (Pubitemid 351704521)
48. J.H. Krystal, L.P. Karper, and J.P. Seibyl Subanaesthetic effects of the non-competitive NMDA antagonist ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine response Arch Gen Psychiatry 51 3 1994 199 214
49. J.A. Leonard 5 Choice Serial Reaction Apparatus Anonymous 1959 Med. Res. Council Appl. Psychol. Res. Unit Rep.; Great Britain
50. G. Le Pen, A.J. Grottick, G.A. Higgins, and J. Moreau Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia Neuropsychopharmacology 28 2003 1799 1809 (Pubitemid 41070845)
51. E.D. Luby, B.D. Cohen, F. Rosenbaum, J. Gottlieb, and R. Kelley Study of a new schizhophrenomimetic drug, sernyl Arch. Neurol. Psychiatry 81 1959 363 369
52. J.F. Mackworth Vigilance, arousal, and habituation Psychol. Rev. 75 4 1968 308 322
53. S.R. Marder, W. Fenton, and K. Youens Schizophrenia, IX: cognition in schizophrenia - the MATRICS initiative Am. J. Psychiatry 161 1 2004 25 (Pubitemid 38419303)
54. H.M. Marston Analysis of cognitive function in animals, the value of SDT Cogn. Brain Res. 3 1996 269 277 (Pubitemid 26198358)
55. R. Mass, K. Wolf, M. Wagner, and C. Haasen Differential sustained attention/vigilance changes over time in schizophrenics and controls during a degraded stimulus Continuous Performance Test Eur. Arch. Psychiatry. Clin. Neurosci. 250 2000 24 30 (Pubitemid 30326369)
56. J. McGaughy, and M. Sarter Behavioural vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands Psychopharmacology (Berl.) 117 3 1995 340 357
57. N.R. Mirza, and I.P. Stolerman Nicotine enhances sustained attention in the rat under specific task conditions Psychopharmacology 138 1998 266 274 (Pubitemid 28365491)
58. C.J. Morgan, M. Riccelli, C.H. Maitland, and H.V. Curran Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users Drug Alcohol Depend. 75 2004 301 308 (Pubitemid 38993300)
59. C.J. Morgan, L. Muetzefeldt, and H.V. Curran Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study Addiction 105 1 2010 121 133
60. R. Murai, Y. Noda, K. Matsui, H. Kamei, A. Mouri, and K. Matsuba Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signalling Behav. Brain Res. 180 2007 152 160 (Pubitemid 46719421)
61. E.R. Murphy, J.W. Dalley, and T.W. Robbins Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task Psychopharmacology 179 2005 99 107 (Pubitemid 40576696)
62. J.L. Muir, T.W. Robbins, and B.J. Everitt AMPA-induced lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function J. Neurosci. 14 1994 2313 2326 (Pubitemid 24108136)
63. Neill, J.C.; Barnes, S.A.; Cook, S.; Grayson, B.; Idris, N.; McLean, S.L.; Snigdha, S.; Rajagopal, L.; Harte, M.K.; 2010. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. doi:10.1016/j.pharmthera.2010.07.004.
64. P.G. Nestor, S.F. Faux, R.W. McCarley, M.E. Shenton, and S.F. Sands Measurement of visual sustained attention in schizophrenia using signal detection analysis and a newly developed computerized CPT task Schizophr. Res. 3 1990 329 332 (Pubitemid 20383968)
65. K.H. Nuechterlein, D.M. Barch, J.M. Gold, T.E. Goldberg, M.F. Green, and R.K. Heaton Identification of separable cognitive factors in schizophrenia Schizophr. Res. 72 1 2004 29 39 (Pubitemid 39452903)
66. K.H. Nuechterlein, M.F. Green, and R.S. Kern The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity Am. J. Psychiatry 165 2008 203 213 (Pubitemid 351704520)
67. J.W. Olney, and N.B. Faber NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins and research tools for studying schizophrenia Neuropsychopharmacology 13 4 1995 335 345 (Pubitemid 26007689)
68. J.W. Olney, J.W. Newcomer, and N.B. Farber NMDA receptor hypofunction model of schizophrenia J. Psychiatr. Res. 33 6 1999 523 533
69. T.A. Paine, and W.A. Carlezon Jr. Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats Neuropharmacology 56 2009 788 797
70. R. Parasuraman The Attentive Brain. A Bradford Book 1998 The MIT Press
71. S.H. Park, J.J. Kim, C.H. Kim, J.H. Kim, and K.H. Lee Sustained attention in the context of emotional processing in patients with schizophrenia Psychiatry Res. 2010 10.1016/j.psychres.2010.11.007
72. T.W. Robbins Arousal and attention: psychopharmacological and neuropsychological studies in experimental animals R. Parasuraman, The Attentive Brain 1998 MIT Press Cambridge 189 220
73. T.W. Robbins The 5-choice serial time task: behavioural pharmacology and functional neurochemistry Psychopharmacology 163 2002 362 380
74. C.A. Riccio, C.R. Reynolds, P. Lowe, and J.J. Moore The continuous performance test: a window on the neural substrates of attention Arch. Clin. Neuropsychol. 17 3 2002 235 272 (Pubitemid 34201745)
75. M. Sarter Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? Psychopharmacology 114 1994 539 550 (Pubitemid 24152133)
76. G.W. Snedecor, and W.G. Cochran Statistical Methods eighth ed. 1989 Iowa State University Press Ames, Iowa pp. 226-228
77. S. Snigdha, J.C. Neill, S.L. McLean, G.K. Shemar, L. Cruise, M. Shahid, and B. Henry Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and assoiciated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female brain J. Mol. Neurosci. 18 2010 10.1007/s12031-010-9447-5
78. C. Spratt, H.M. Marston, J. Sharkey, and J.S. Kelly Comparison of rat and mouse attentional performance in the 5-choice serial reaction time task BNA 17 2000 49.03
79. T. Steckler Using signal detection methods for analysis of operant performance in mice Behav. Brain Res. 125 2001 237 248 (Pubitemid 33000462)
80. I.P. Stolerman, N.R. Mirza, B. Hahn, and M. Shoaib Nicotine in an animal model of attention Eur. J. Pharmacol. 393 2000 147 154 (Pubitemid 30193411)
81. D. Umbricht, L. Schmid, R. Koller, F.X. Vollenweider, D. Hell, and D.C. Javitt Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers Arch. Gen. Psychiatry 57 2000 1139 1147
82. Q. Wang, R. Chan, J. Sun, J. Yao, W. Deng, X. Sun, X. Liu, P.C. Sham, X. Ma, H. Meng, R.M. Murray, D.A. Collier, and T. Li Reaction time of the continuous performance test is an endophenotypic marker for schizophrenia: a study of first-episode neuroleptic-naive schizophrenia, their non-psychotic first-degree relatives and healthy population control Schizophr. Res. 89 1-3 2007 293 298 (Pubitemid 44881300)
83. R.T. Wilkinson Interaction of noise with knowledge of results and sleep deprivation J. Exp. Psychol. 66 1963 332 337
84. C.A. Winstanley, Y. Chudasama, J.W. Dalley, D.E.H. Theobald, J.C. Glennon, and T.W. Robbins Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats Psychopharmacology 167 3 2003 304 314 (Pubitemid 36712978)
85. J.W. Young, N. Crawford, J.S. Kelly, L.E. Kerr, and H.M. Marston Impaired attention is central to the cognitive deficit observed in alpha 7 deficient mice Eur. Neuropsychopharmacol. 17 2007 145 155 (Pubitemid 44802833)
86. J.W. Young, S.B. Powell, V. Risbrough, H.M. Marston, and M.A. Geyer Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia Pharmacol. Therapeut. 122 2009 150 202
87. J.W. Young, G.A. Light, H.M. Marston, R. Sharp, and M.A. Geyer The 5-Choice performance test: evidence for a translational test of vigilance for mice PLoS ONE 4 2009 e4227
88. J.W. Young, S.B. Powell, C.N. Scott, X. Zhou, and M.A. Geyer Reduced dopamine D4 receptor expression as a mouse model of ADHD: evidence of impaired vigilance in the 5-choice continuous performance test Behav. Brain Res. 222 1 2011 183 192